These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 20549700

  • 41. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
    Zhang H, Jiang H, Wang W, Gong J, Zhang L, Chen Z, Ding Q.
    Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
    [Abstract] [Full Text] [Related]

  • 42. MiR-124 retards bladder cancer growth by directly targeting CDK4.
    Zhang T, Wang J, Zhai X, Li H, Li C, Chang J.
    Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1072-9. PubMed ID: 25348738
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog.
    Tan M, Mu X, Liu Z, Tao L, Wang J, Ge J, Qiu J.
    Biochem Biophys Res Commun; 2017 Feb 05; 483(2):867-873. PubMed ID: 28069380
    [Abstract] [Full Text] [Related]

  • 45. Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
    Li S, Zhu Y, Liang Z, Wang X, Meng S, Xu X, Xu X, Wu J, Ji A, Hu Z, Lin Y, Chen H, Mao Y, Wang W, Zheng X, Liu B, Xie L.
    Oncotarget; 2016 Aug 09; 7(32):51773-51783. PubMed ID: 27429046
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C.
    Carcinogenesis; 2011 Aug 09; 32(8):1183-9. PubMed ID: 21665894
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.
    Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q, Chen J, Chen X, Zhang S, Liu Z, Zhou J, Zhu Y, Deng Y, Zheng Y, Bi F.
    Int J Cancer; 2011 Mar 15; 128(6):1269-79. PubMed ID: 20473940
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M, Jiang Z, Zhang X, Lu D, Ha AD, Sun J, Du W, Wu Z, Hu L, Khadarian K, Shen J, Lin Z.
    Carcinogenesis; 2014 Aug 15; 35(8):1698-706. PubMed ID: 24480809
    [Abstract] [Full Text] [Related]

  • 57. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
    Bai S, Tian B, Li A, Yao Q, Zhang G, Li F.
    Eye (Lond); 2016 Dec 15; 30(12):1630-1638. PubMed ID: 27518550
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.